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Introduction
Bronchial carcinoma is the second most commonly
diagnosed cancer, and is currently the number one
cause of cancer death in the UK. Smoking is the major
risk factor for the development of bronchial carcinoma
and trends in smoking habits are reflected in incidence
rates. Poor survival is due in part, to late development
of symptoms, and a tendency for the presence of meta-
static spread at presentation. This study aims to evaluate
the efficacy of current treatments and whether or not
prevention strategies should play a more prominent role
in the future.
Methods
Studies were selected for review from the electronic data-
bases Medline and Pubmed, based on keyword search
terms. Articles were then screened by title and abstract
to assess their suitability for inclusion. Selected article
references were screened manually for further source
material. All articles were limited by English language
and publication date post 1995.
Results
Key studies indicate that treatment for limited stage dis-
ease is often curative, however over 60% of patients pre-
sent with stage III or IV disease, and therefore treatment
in this group is often palliative. Preventative measures
such as the smoking ban have not yet been proven to
reduce incidence rates, although studies have shown
decreased levels of environmental carcinogens since the
ban. Chemoprevention studies utilising nutritional supple-
mentation identified selenium as reducing the relative risk
of developing bronchial carcinoma. Furthermore, whilst
screening programmes have shown earlier detection rates,
this has not decreased associated mortality.
Conclusions
The review suggests that current treatments are often lim-
ited by the extent of the disease process, and as such, are
largely palliative. Late presentation and early metastases
account for this situation and although there is limited
data, current evidence suggests that screening pro-
grammes may not show any benefit in terms of mortality.
It is therefore evident that more needs to be done to help
prevent the development of bronchial carcinoma.
Although preventative measures such as the smoking ban
are likely to reduce mortality, this is evidently a long-term
solution and interim measures, such as chemoprevention,
should be considered in high risk groups.
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